Lv1
18 积分 2022-08-16 加入
Tackling Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Cancer
5个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
5个月前
已完结
Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer
8个月前
已完结
Overcoming therapy resistance in EGFR-mutant lung cancer
9个月前
已完结
20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight
9个月前
已完结
皖公网安备34019202002308
